Celltrion, Stock Price Down 2.32% at This Hour... Foreigners Net Sell 393,741 Shares in Last 5 Days

As of 12:30 PM on the 8th, Celltrion is trading at 294,500 KRW, down 2.32% from the previous day. The trading volume is 299,982 shares, which is 66.05% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On March 3rd, Hana Financial Investment researcher Sun Min-jung stated, "EMA in Europe has initiated a Rolling Review for Regkirona. If Regkirona is marketed in the US or European markets, Celltrion is expected to see a significant increase in performance this year. Ultimately, if it succeeds in entering the US or European markets where the number of patients is large and drug prices are set high, the sales of Regkirona are expected to be on a scale incomparable to existing biosimilars." She set Celltrion's target price at 390,000 KRW.

Over the past five days, individual investors have net purchased 365,671 shares of Celltrion, while foreigners and institutions have net sold 393,741 shares and net purchased 19,935 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.